August 2011- Volume 7, Issue 8
August 2011
In this Issue
Diagnostics
Hitting a molecular diagnostics high
Hitting a molecular diagnostics high
Luminex finalizes deal to acquire EraGen Biosciences
The ultimate test of a relationship
The ultimate test of a relationship
SQI Diagnostics acquires Scienion AG
Treatment at the time of diagnosis
Treatment at the time of diagnosis
Metamark Genetics partners with Definiens on development, commercialization of tissue-based cancer diagnostics
For those who do inhale
For those who do inhale
Allegro Diagnostics licenses lung cancer molecular testing platform to Boston University, U of Utah Foundation
Doing the two-step
Doing the two-step
QIAGEN looks to buy a huge stake in Ipsogen and then acquire the rest later in effort to expand leadership role in oncology molecular diagnostics
Contract Services
NexACT for Apricus, BioTox
NexACT for Apricus, BioTox
Apricus Biosciences sells Bio-Quant CRO subsidiary to BioTox Sciences; both companies shift focus
Quintiles and the Queen
Quintiles and the Queen
The company’s prime site program goes live at Queen Mary University, aims to accelerate clinical research
AMRI and Proteros Biostructures announce strategic alliance
AMRI and Proteros Biostructures announce strategic alliance
Combination of structural biology services and drug discovery capabilities aims to provide 'integrated solutions from one point of service and contact'
Try it, you'll like it!
Try it, you'll like it!
After a months-long collaboration, CanAm Bioresearch and EpiTherapeutics sign a formal medicinal chemistry research agreement
Skin is in for Valeant
Skin is in for Valeant
Canadian pharma snags dermatology assets with two acquisitions totaling $770 million
Instruments & Informatics
A capital transaction
A capital transaction
Berlin's Eckert & Ziegler acquires the analytic instrumentation and radiochemistry equipment business from Washington, D.C.-based Bioscan
Swiss design and Arizona necessity converge
Swiss design and Arizona necessity converge
Tecan collaborates with TGen and ASU Biodesign Institute on comprehensive sample preparation solution for proteomic research
Terminating NGS data hassles
Terminating NGS data hassles
LaserGen, National Instruments collaborate to improve accuracy of DNA sequencing
SANYO and BD Biosciences collaborate on life sciences tools
SANYO and BD Biosciences collaborate on life sciences tools
SANYO North America Corp.’s Biomedical Solutions Division and BD Biosciences, a segment of Becton, Dickinson and Co., last month announced a strategic agreement to jointly promote cutting-edge life science research tools designed to advance cell culture and cell therapy research.
Molecular Devices snaps up Genetix
Molecular Devices snaps up Genetix
Genetix products are cited as key to the transaction
Omics & Systems Biology
Finding GEMS
Finding GEMS
AstraZeneca, PTC Therapeutics announce strategic oncology drug discovery collaboration
Two heads are better than one
Two heads are better than one
LGC’s Genomics division combines with KBioscience with aim of creating a market leading genomics position
Banking on biotherapeutics
Banking on biotherapeutics
Promega partners with ATCC to offer new cell systems for biologics drug discovery
An ‘aha’ moment
An ‘aha’ moment
University of Colorado School of Medicine seeks funding for $5 million clinical trial for drug to halt progression of Parkinson\'s disease
Proteome Sciences and Moffitt Cancer Center collaborate on clinical mass spec assays for assessment of cancer patien
Proteome Sciences and Moffitt Cancer Center collaborate on clinical mass spec assays for assessment of cancer patien
Proteome Sciences PLC, a global leader in applied proteomics and peptidomics, has entered into a collaboration agreement with the renowned Moffitt Cancer Center to develop mass spectrometry assays measuring certain key signaling and repair pathway proteins that can be adapted for tumor biopsy analysis in the clinic.
On the trail of oncology biomarkers
On the trail of oncology biomarkers
Evotec-Roche collaboration to focus on identifying protein-phosphorylations
Research & Development
A 'killer' combination
A 'killer' combination
BMS, Innate Pharma collaborate on NK cell-activating antibody
Seen but not heard
Seen but not heard
Sanofi and Audion Therapeutics quietly partner on potential treatments for hearing loss
Gilead pursues ‘one-a-day’ HIV pill
Gilead pursues ‘one-a-day’ HIV pill
Biopharma teams up with J&J to fight virus that causes AIDS
From Boston to Brussels
From Boston to Brussels
Belgium’s UCB launches research alliance with Harvard University
Getting in the zone
Getting in the zone
BioZone Pharma acquires BioZone Labs, related companies for 21 million stock shares
Crucell, Scripps researchers find broadly acting flu antibody
Crucell, Scripps researchers find broadly acting flu antibody
Discovery of natural antibody could bring universal flu vaccine a step closer
A toothsome BiTE
A toothsome BiTE
Micromet inks cancer drug deal with Amgen that could be worth just over $1 billion
Global News
Worth weighting for?
Worth weighting for?
Zealand Pharma and Boehringer Ingelheim to work on novel compounds to treat type 2 diabetes and obesity
Russian toward innovation
Russian toward innovation
Pfizer and ChemRar High Tech Center to explore innovative medical R&D partnership in Russia
Bridging the industry-academia gap
Bridging the industry-academia gap
Canada's Centre for Drug Research and Development teams up with Germany's Lead Discovery Center to use basic research to develop 'promising innovations' for several diseases
Eyeing a bright future
Eyeing a bright future
MingSight, Relin form joint venture in China to develop novel treatment for diabetic eye disease
Harvard Bioscience acquires CMA Microdialysis' preclinical business
Harvard Bioscience acquires CMA Microdialysis' preclinical business
Harvard Bioscience Inc., a global developer of tools for life science research and regenerative medicine, announced last month that it has acquired the preclinical business unit of CMA Microdialysis AB through a purchase of assets.
Royal wedding
Royal wedding
Royalty Pharma adds an Astellas brand to its big-name portfolio
Special Reports
ddn Editorial Roundtable: Ethics and stem cell research
ddn Editorial Roundtable: Ethics and stem cell research
Researchers discuss the ethical, moral and scientific concerns associated with stem cell research
Root to stem
Root to stem
In new survey, we try to get to the bottom of perceptions on stem cells and other R&D efforts
Commentary
The changing face of regulatory outsourcing
The changing face of regulatory outsourcing
In a supercharged business and regulatory climate, life sciences companies large and small are turning to outsourcing vendors to manage tactical tasks and help them adopt best practices.
So many innovation strategies …
So many innovation strategies …
In the last month or so, I’ve read white papers, CEO speeches, editorials and op-eds in response to what some now call a crisis in innovation, perhaps to mirror the purported crisis in education.
Editor's Focus
Embryonic stem cell research: A Dickey-Wicker of a situation
Embryonic stem cell research: A Dickey-Wicker of a situation
Isn’t it about time Congress revisited what is essentially an afterthought on a 15-year-old appropriations bill, clearly articulated the facts and concerns about hESC research and put forth a specific policy on the matter?
